← Back to RAPP Overview
Rapport Therapeutics, Inc. Common Stock (RAPP)
Price-to-Earnings Ratio History
P/E Ratio (TTM)
-18.63
Financial Fundamentals
RAPP • Quarterly Data • 5Y View
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2023-03-31 | -164.56 |
| 2023-06-30 | -163.01 |
| 2023-09-30 | -114.04 |
| 2023-12-31 | -69.52 |
| 2024-03-31 | -43.33 |
| 2024-06-30 | -12.72 |
| 2024-09-30 | -10.24 |
| 2024-12-31 | -7.78 |
| 2025-03-31 | -3.69 |
| 2025-06-30 | -3.79 |
| 2025-09-30 | -10.46 |
| 2025-12-31 | -10.53 |
| 2026-03-31 | -18.63 |
* P/E ratios are calculated using trailing twelve-month (TTM) earnings.